Current management of diabetes patients with COVID-19.

Misra, Arup Kumar; Rangari, Gaurav; C, Madhavrao; Sharma, Sushil

Misra, Arup Kumar; Rangari, Gaurav; C, Madhavrao; Sharma, Sushil.

Afiliación

Misra AK; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Mangalagiri, India.
Rangari G; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Mangalagiri, India.
C M; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Mangalagiri, India.
Sharma S; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Mangalagiri, India.

Expert Rev Endocrinol Metab ; : 1-9, 2023 Mar 08.

Article en En | MEDLINE | ID: mdl-36890686

Palabras clave

COVID-19; antidiabetic drugs; diabetes mellitus; infection; inflammation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Expert Rev Endocrinol Metab Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google